Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate
Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate
Bluejay Diagnostics第四季度每股收益美元(1.78美元)未達到預期(0.68美元)
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.68) by 161.76 percent. This is a 25.83 percent increase over losses of $(2.40) per share from the same period last year.
Bluejay Diagnostics(納斯達克股票代碼:BJDX)公佈的季度虧損爲每股1.78美元,比分析師普遍預期的0.68美元(0.68美元)低161.76%。這比去年同期每股虧損2.40美元(2.40美元)增長了25.83%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。